Overview

A Study to Evaluate the Effect of 2 Drugs on the Pharmacokinetics of BMS-986205 in Healthy Subjects

Status:
Completed
Trial end date:
2017-12-20
Target enrollment:
Participant gender:
Summary
Assess the effects of itraconazole and rifampin on the pharmacokinetics, safety, and tolerability of BMS-986205.
Phase:
Phase 1
Details
Lead Sponsor:
Bristol-Myers Squibb
Treatments:
Hydroxyitraconazole
Itraconazole
Linrodostat
Rifampin